Clinical trials recruiting in Flossmoor, Illinois

Phase breakdown

Conditions recruiting in Flossmoor, Illinois

Recruiting trials in Flossmoor, Illinois

• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
  NCT07674654 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Sigvotatug Vedotin in Advanced Solid Tumors
  NCT04389632 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
  NCT07645924 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Flossmoor, Illinois?

3 recruiting trials have at least one study site in Flossmoor, Illinois.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.